Yahoo Finance

MBX Biosciences Closes $115 Million Series B Financing to Advance Development of Endocrine Disease Programs

CARMEL, Ind., Nov. 14, 2022 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptide™ (PEP™) therapeutics to treat an array of ...
Yahoo Finance

MBX Biosciences Raises $63.5 Million in Series C Financing to Advance Precision Endocrine Peptide™ (PEP™) Platform

CARMEL, Ind., Aug. 05, 2024 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the ...
BioWorld

Gland opening: MBX series A draws $34.6M as players reunite for endocrine push

As Carmel, Ind.-based MBX Biosciences Inc., taking aim at rare endocrine diseases, disclosed $34.6 million in a series A financing, CEO and co-founder Kent Hawryluk told BioWorld that “everyone on the ...
WSPA

Tark Thermal Solutions’ MBX Series Micro Thermoelectric Coolers Empower Next-Gen Pluggables for AI Data Centers

Engineered for thin profiles, high heat packing densities and scalability, MBX coolers position AI data centers and telecom providers to meet tomorrow’s bandwidth demands with confidence.” — Andrew ...
MarketWatch

MBX Biosciences Raises $63.5 Million in Series C Financing to Advance Precision Endocrine Peptide(TM) (PEP(TM)) Platform

The MarketWatch News Department was not involved in the creation of this content. MBX Biosciences Raises $63.5 Million in Series C Financing to Advance Precision Endocrine Peptide(TM) (PEP(TM)) ...